Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice by Fang Lv, Xiaoling Cai, Chu Lin, Wenjia Yang, Linong Ji

Subjects: “…GLP-1 receptor agonists…”
Get full text

Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses by Hsuan-Wen Lai, Jui-Yi Chen, Vin-Cent Wu, Chun Yin See

Subjects: “…GLP-1 receptor agonist…”
Get full text

Semaglutide, liraglutide and tirzepatide: Comparison of effectiveness in the treatment of obesity – a literature review by Karolina Baran, Marlena Jankowska, Natalia Jańczyk, Karolina Mędrysa, Jakub Pokrzepa, Michał Presak, Gabriela Blecharz, Julia Szwech, Alicja Winkowska, Jan Machalica

Subjects: Get full text

Pulmonary artery pressure trajectories in heart failure patients treated with GLP‐1 receptor agonists by Haoran Jiang, Phuuwadith Wattanachayakul, Veraprapas Kittipibul, Erika Nicolsen, Todd McVeigh, Oksana Kamneva, Marat Fudim

Subjects: “…GLP‐1 receptor agonist…”
Get full text

Improving the Quality of Two Lives by Treating Obesity by Norbert Nagy, Patrícia Kleinová, Martin Jozef Péč, Matej Samoš, Ivana Dedinská

Subjects: Get full text

Glucagon-like peptide 1 receptor agonists: A new approach to type 2 diabetes management by Lynn Lambert

Subjects: Get full text

Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observ... by Anders Boisen Jensen, Ursina Machado, Frida Renström, Stefan Aczél, Patrick Folie, Magdalena Biraima-Steinemann, Stefan Bilz

Subjects: Get full text

Relative Effectiveness and Safety of the GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists, Semaglutide and Liraglutide in the Treatment of Obese Type 2 Diabetics: A Prospective Ob... by Hoffmann K, Michalak M, Paczkowska A

Subjects: “…GLP-1 receptor agonist…”
Get full text

Rhabdomyolysis associated with the use of tirzepatide by Kunal Sonavane, Pallavi Shirsat, Gautam Agrawal, Bhawna Agarwal

Subjects: Get full text

Dietary Recommendations for the Management of Gastrointestinal Symptoms in Patients Treated with GLP-1 Receptor Agonist by Gentinetta S, Sottotetti F, Manuelli M, Cena H

Subjects: Get full text

Novel antidiabetic therapies in patients with peripheral artery disease: current perspective by Miodrag Janić, Miodrag Janić, Miodrag Janić, Viviana Maggio, Andrej Janež, Andrej Janež, Manfredi Rizzo, Manfredi Rizzo

Subjects: Get full text

The Potential Role of Glucagon-Like Peptide-1 Receptor Agonists in Polycystic Ovary Syndrome: A Narrative Review by Kamil Turlej, Dmytro Kowalczuk, Viktoryia Kasianik, Darya Lazitskaya, Mykola Sobchynskyi, Valeryia Milasheuskaya, Andrii Myrnyi, Iga Kiełbaszewska, Natallia Surosz, Katsiaryna Miraniuk

Subjects: Get full text

Liver function effects of SGLT2 inhibitor and GLP‐1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study) by Daisuke Tsuriya, Kazuo Kobayashi, Kei Takeshita, Takuya Hashimoto, Moritsugu Kimura, Yoshimi Muta, Hisashi Yokomizo, Yuichi Takashi, Shunichiro Tsukamoto, Kouichi Tamura, Keizo Kanasaki, Daiji Kawanami, Masao Toyoda

Subjects: Get full text

Semaglutide as a GLP-1 Agonist: A Breakthrough in Obesity Treatment by Rui Salvador, Carla Guimarães Moutinho, Carla Sousa, Ana Ferreira Vinha, Márcia Carvalho, Carla Matos

Subjects: Get full text

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Evolving Insights into Pathogenesis, Progression, and Personalized Treatment Approaches by Paweł Kukiełka, Katarzyna Moliszewska, Joanna Kośka, Kacper Dywan, Michał Błaszkiewicz, Julia Mazurek, Julia Załęcka, Alicja Nowik, Martyna Musiorska, Gabriela Łocik

Subjects: Get full text

Case Report: Rhabdomyolysis following initiation of tirzepatide by Jonas Michael Bodanowitz, Isabell Mattes, Micha Loebermann, Carlos Fritzsche

Subjects: Get full text

Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review by Andrijana Koceva, Andrijana Koceva, Katarina Mlekuš Kozamernik, Katarina Mlekuš Kozamernik, Andrej Janež, Andrej Janež, Rok Herman, Rok Herman, Simona Ferjan, Simona Ferjan, Mojca Jensterle, Mojca Jensterle

Subjects: Get full text

Role of physical activity in GLP-1 receptor agonist therapy for obesity treatment by Łukasz Zdziebkowski, Hanna Wilska, Dorota Szatkowska, Dominika Ziętara, Kacper Kmieć, Aleksandra Topolska, Marcin Komorowski, Michał Janiszewski, Natalia Surosz, Michał Grochowalski, Aleksandra Graczyk, Jakub Szydło

Subjects: “…GLP-1 receptor agonist…”
Get full text

A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia by Luigi Vetrugno, Cristian Deana, Andrea Da Porto, Enrico Boero, Valentina Bellini, Daniele Guerino Biasucci, Elena Giovanna Bignami

Subjects: “…GLP-1 receptor agonists…”
Get full text

Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma by Zaynab A. Mouhammad, Anne Rombaut, Mariana Yolotzin García Bermúdez, Rupali Vohra, James R. Tribble, Pete A. Williams, Miriam Kolko

Subjects: Get full text